An Association Study of the Signal Transducer and Activator of Transcription 6 Gene With Periodic Psychosis by Kawashige, Seiya et al.
 
 
 
 
online © ML Comm  
www.psychiatryinvestigation.org 41 
0ORIGINAL ARTICLE0 
Print  ISSN 1738-3684 / On-line  ISSN 1976-3026
Copyright ⓒ 2008 Official Journal of Korean Neuropsychiatric Association
Psychiatry Invest 2008;5:41-44 
 
An Association Study of the Signal Transducer and 
Activator of Transcription 6 Gene With Periodic Psychosis 
 
 
 
ObjectiveᄏRecent molecular and genetic investigations have suggested that the current no-
sology for major psychiatric disorders, based on the “two-entities-principal” is not accurate 
with respect to clinical observations; patient groups that do not fit to the current operative 
diagnostic boundaries are readily identified. We aimed to perform an investigation of the 
signal transducer and activator of transcription 6 (STAT6) gene (located on 12q13), which 
has an important role in the apoptotic cascade, with patients suffering from periodic psy-
chosis. 
MethodsᄏGenetic association study has been employed for the current work. Investigated 
six tag-SNPs were chosen from Hapmap database. 
ResultsᄏAmong six tag-SNPs, one marker (rs10783813), located in the STAT6 gene, 
showed modest association (p<0.05), although no marker or haplotype block showed 
association after Bonferroni’s correction. 
ConclusionᄏFuture studies will reveal the etiological role of STAT6, and of other genes 
of the apoptotic cascade, in major psychiatric disorders. 
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Introduction 
 
Recent molecular genetic investigations of major psychiatric disorders have re-
sulted in skepticism of the accuracy of the “two-entities-principle”. The two-entities-
principal postulates that major psychiatric disorders are divided into two groups,
namely schizophrenia and bipolar disorder. This nosology was proposed by Krae-
pelin
1,2 in the 19
th century and, despite criticism, it has survived through the cen-
turies and still influences current operational diagnostics, such as the International
Classification of Disease (ICD)
3 for the Diagnostic and Statistical Manual of Men-
tal Disorders (DSM).
4 These classification systems have reduced the confusion 
between clinicians tra ined under different schools and their use has, therefore,
become widespread all over the world. Although these classifications have been up-
dated several times, the concept of Kraepelin’s dichotomy still remains. However it 
has been difficult to clinically divide patients. Even in the field of molecular ge-
netics there are several genes, such as Neureglin 1 (NRG1)
5,6 and Disrupted in 
Schizophrenia 1 (DISC1),
7,8 that are candidates for both bipolar disorder and for 
schizophrenia. This accumulated evidence suggests that the current nosology is not
appropriate for precisely separating the major psychiatric disorders, nor for investi-
gating candidate gene(s). Before the concerns of these operative criteria, schools 
named the patient group suffering from periodic psychosis as bouffés délirantes 
(French), reactive psychose (Northern Europe), schizoaffective psychosis (North 
America), psychogene Geisteskrankheitsformen (Denmark), zykloide Psychosis 
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(German), and atypical psychosis (Japan). Although there 
were differences among these classifications, the past 
advocates labeled patients with this pathology due a 
better prognosis compared to those with common psy-
chosis. This clinical insight is important with respect to 
treatment, while accurate taxonomy is essential to deter-
mine precise etiology. In the current study, using an as-
sociation method, we aimed to determine genetic factors 
that are involved in this periodic psychosis. The DNA 
samples recruited were grouped according to three relati-
vely solid criteria: 1) In a longitudinal time course, psy-
chotic symptoms occur episodically, with partial or full 
remission, 2) Onset of prominent psychotic symptoms 
within 4 weeks of the first noticeable change from usual 
behavior or functioning, 3) Confusion of perplexity at 
the height of the psychotic episode (The description of 
1) is derived from schizophrenia in DSM-IV. 2) and 3) 
are derived from schizophreniform disorder with good 
prognostic features). Sixty-nine samples were collected 
in the western area of Japan under these criteria. 
Recent neuroimaging studies have identified low vol-
umes of cortical gray matter in schizophrenia and sug-
gested that apoptosis (programmed cell death) might cause 
this change.
9,10 Apoptosis induces the up-regulation of 
prostaglandin E2 (PGE2), which suppresses T helper 
cell 1 (Th1) cytokine, resulting in a status known as the 
Th2 shift. Avgustin et al. reported a Th2 shift (Th2 > Th1) 
in patients with a relapse of schizophrenic symptoms.
11 
The Th2 shift increases mRNA levels of interleukin-4, 
which is a main cytokine of Th2. Interleukin-4 subse-
quently induces the phosphorylated signal transducer 
and activator of transcription 6, (STAT6) (locating on 12q 
13). STAT6 is a transcriptional activator of Bcl-XL, which 
is a potent inhibitor of apoptosis. STAT6-deficient mice 
demonstrate the down-regulation of striatal dopamine 
transporter (DAT), weaker Prepulse Inhibition (PPI) and, 
in addition, they become hyperactive.
12,13 Therefore, the 
absence of STAT6 results in the alteration of dopamine 
levels and of apoptosis in the brain. It is suspected that 
the progressive volume decrease of gray matter in 
schizophrenia is caused by the disturbance of this cascade. 
In periodic psychosis, continuous decline of social level 
is seldom seen, so it is not expected that significant apop-
tosis occurs in such patients. In schizophrenic brain, show-
ing progressive recession, we hypothesized that STAT6, 
which is located down-stream in the apoptotic cascade, 
might be a cause of periodic psychosis. In addition, acute 
symptoms of periodic psychosis include an inflammatory 
response that is reversible with treatment by antipsy-
chotic drugs. Therefore, we aimed to reveal the relation-
ship between STAT 6 and periodic psychosis using the 
method of genetic association. 
 
Methods 
 
Subjects 
Sixty-nine periodic psychosis subjects were recruited, 
while 123 normal controls were investigated. Two or 
more psychiatrists reviewed all of the recruited partici-
pants, who are ethnically Japanese. Informed consent was 
obtained from each subject. 
 
Single nucleotide polymorphism selection 
Six single nucleotide polymorphisms (SNPs) were sel-
ected according to the following criteria; 
1) Suggested as tag SNP by Hapmap data (Data Re-
leased #22, dbSNP b126). 
2) Minor allele frequency is greater than 0.05 in a 
Japanese population. The detail of the six selected SNPs, 
primers and probes are shown in Table 1. Genotyping 
was performed by the fluorescence resonance energy tr-
ansfer method (FRET) using the Light Cycler System 
(Roche). Statistical analysis was performed by SPSS 
software (ver 15.0) and by Haploview (ver 4.0).
14 
 
Ethical consideration 
The current study was approved by the ethical comm-
ittee of Osaka Medical College, Japan. 
 
Results 
 
One single SNP (rs10783813) showed a significant 
association  (p=0.0458, not corrected), although it did 
not reach significance level after Bonferroni’s correction 
TABLE 1. Results of single nucleotide polymorphisms (SNPs)
Reference SNPs  Association allele  Case counts  Control counts  Case ratio  Control ratio  Chi-square  p-value 
 rs70381700  G  115 vs 23  189 vs 057  0.833  0.768  2.268  0.1321* 
 rs32401500  A  090 vs 48  145 vs 101  0.652  0.589  1.466  0.2260* 
 rs30249740  C  122 vs 16  212 vs 034  0.884  0.862  0.387  0.5338* 
 rs84171800  C  111 vs 27  176 vs 070  0.804  0.715  3.701  0.0544* 
 rs10783813  G  088 vs 50  131 vs 115  0.638  0.533  3.990  0.0458* 
 rs16776900  C  115 vs 23  184 vs 062  0.833  0.748  3.738  0.0532* 
*Modest significance without multiple-test correction 
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(Table 1). In addition, several markers, such as rs841718 
and rs167769, indicated the tendency to be associated 
with periodic psychosis. After the testing by Haploview, 
two blocks were constructed (Figure 1). Only one LD-
block haplotypes (T-T-C in Block 2, Figure 2) indicated 
an association with the illness of interest in this research 
(p=0.042), while this pattern did not survive after the 
multiple-test correction. 
 
Discussion 
 
The limitation of this study was the relatively smaller 
number of subjects chosen, due to the solid criteria for 
periodic psychosis adopted. Of the SNPs analyzed we 
found only a tendency for association. None of the single 
markers showed association after Bonferroni’s Correction, 
while no haplotype showed significance of less than 0.05. 
Therefore, we are only able to state that STAT6 has a 
tendency to be associated with periodic psychosis. One 
further concern is not to be able to demonstrate the SNP 
association data of schizophrenia itself; clearer conclu-
sions could be drawn if we could compare our data with 
that for schizophrenia. 
As described before, the current nosology for major 
psychiatric disorders has been influenced by the hypo-
thesis proposed by Kraepelin. Mitsuda of Osaka Med-
ical College, proposed the concept named “atypical psy-
chosis” in 1941. This concept is characterized by better 
long-term prognosis and confusional state with acute 
onset. The prevalence in females is generally greater than 
in males. Although this concept not adopted in the recent 
classification systems, it is still easy to find patients whose 
diagnosis lies across the two major psychoses. So far, 
several studies on the endophenotypes, detected by CT
15 
or by MRI,
16 have shown better structural alteration in 
the brain of “atypical psychosis” suffers compared to that 
in schizophrenic brain. Moreover, the present study found 
a tendency of STAT6 to be associated with “atypical psy-
chosis”. Periodic onset of psychosis is regarded as part 
of the course of schizophrenia, however, the possibility 
of “atypical psychosis” must be ruled out in order to re-
duce the unnecessary use of antipsychotic agents. The 
current investigation may potentially explain the mecha-
nism of periodic onset of psychosis, although future work 
will be needed to reveal the etiological role of STAT6 at 
the molecular level. 
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FIGURE 1. Linkage disequilibrium block structure (high D’ block 
is shown in deep red). 
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